Abstract
C32H20O2S2, monoclinic, P21/c (no. 14), a = 10.2763(8) Å, b = 19.9178(15) Å, c = 11.8597(10) Å, β = 92.828(3)°, V = 2424.3(3) Å3, Z = 4, Rgt(F) = 0.069, wR(F2) = 0.1782, T = 293(2).
The asymmetric unit of the title crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.
Crystal: | Yellow plate |
Size: | 0.49 × 0.45 × 0.06 mm |
Wavelength: | Mo Kα radiation (0.71073 Å) |
μ: | 2.5 cm−1 |
Diffractometer, scan mode: | Bruker APEX-II, φ and ω |
2θmax, completeness: | 55°, >99% |
N(hkl)measured, N(hkl)unique, Rint: | 46788, 5560, 0.170 |
Criterion for Iobs, N(hkl)gt: | Iobs > 2 σ(Iobs), 3412 |
N(param)refined: | 325 |
Programs: | SHELX [10], Bruker programs [11] |
Atom | x | y | z | Uiso*/Ueq |
---|---|---|---|---|
S1 | −0.64720(8) | −0.43422(4) | −0.07815(7) | 0.0413(2) |
S2 | −0.44743(9) | −0.41162(4) | −0.26422(7) | 0.0433(2) |
O1 | −0.7921(2) | −0.48721(12) | 0.10123(18) | 0.0521(6) |
O2 | −0.2912(3) | −0.41789(12) | −0.4521(2) | 0.0663(8) |
C1 | −0.6988(3) | −0.51734(13) | −0.0661(2) | 0.0334(7) |
C2 | −0.6380(3) | −0.56051(13) | −0.1372(2) | 0.0293(6) |
C3 | −0.5453(3) | −0.52560(13) | −0.2022(2) | 0.0301(6) |
C4 | −0.4518(3) | −0.54316(14) | −0.2842(2) | 0.0307(6) |
C5 | −0.3930(3) | −0.48624(14) | −0.3250(3) | 0.0361(7) |
C6 | −0.5461(3) | −0.45701(14) | −0.1818(2) | 0.0343(7) |
C7 | −0.7937(3) | −0.52680(15) | 0.0222(2) | 0.0356(7) |
C8 | −0.8903(3) | −0.58276(15) | 0.0159(2) | 0.0361(7) |
C9 | −0.9256(4) | −0.61272(18) | 0.1150(3) | 0.0505(9) |
H9A | −0.8905 | −0.5973 | 0.1840 | 0.061* |
C10 | −1.0123(4) | −0.6652(2) | 0.1117(4) | 0.0638(11) |
H10A | −1.0338 | −0.6862 | 0.1784 | 0.077* |
C11 | −1.0673(4) | −0.6867(2) | 0.0105(4) | 0.0642(11) |
H11A | −1.1254 | −0.7225 | 0.0087 | 0.077* |
C12 | −1.0369(3) | −0.65568(19) | −0.0888(3) | 0.0560(9) |
H12A | −1.0761 | −0.6695 | −0.1572 | 0.067* |
C13 | −0.9479(3) | −0.60387(16) | −0.0853(3) | 0.0428(8) |
H13A | −0.9264 | −0.5830 | −0.1520 | 0.051* |
C14 | −0.6686(3) | −0.63324(13) | −0.1498(2) | 0.0287(6) |
C15 | −0.6580(3) | −0.67707(14) | −0.0595(2) | 0.0353(7) |
H15A | −0.6261 | −0.6618 | 0.0106 | 0.042* |
C16 | −0.6947(3) | −0.74371(16) | −0.0728(3) | 0.0458(8) |
H16A | −0.6859 | −0.7732 | −0.0121 | 0.055* |
C17 | −0.7439(4) | −0.76592(15) | −0.1757(3) | 0.0482(9) |
H17A | −0.7713 | −0.8102 | −0.1839 | 0.058* |
C18 | −0.7531(3) | −0.72332(16) | −0.2667(3) | 0.0473(9) |
H18A | −0.7850 | −0.7389 | −0.3366 | 0.057* |
C19 | −0.7147(3) | −0.65718(14) | −0.2541(2) | 0.0356(7) |
H19A | −0.7199 | −0.6285 | −0.3160 | 0.043* |
C20 | −0.4207(3) | −0.61329(14) | −0.3135(2) | 0.0330(7) |
C21 | −0.3739(3) | −0.65675(15) | −0.2294(3) | 0.0427(8) |
H21A | −0.3627 | −0.6413 | −0.1556 | 0.051* |
C22 | −0.3439(4) | −0.72208(17) | −0.2536(4) | 0.0604(11) |
H22A | −0.3137 | −0.7508 | −0.1962 | 0.073* |
C23 | −0.3583(4) | −0.74463(19) | −0.3611(5) | 0.0722(13) |
H23A | −0.3367 | −0.7888 | −0.3775 | 0.087* |
C24 | −0.4043(4) | −0.7031(2) | −0.4462(4) | 0.0688(13) |
H24A | −0.4150 | −0.7193 | −0.5196 | 0.083* |
C25 | −0.4349(3) | −0.63694(18) | −0.4229(3) | 0.0481(9) |
H25A | −0.4649 | −0.6085 | −0.4808 | 0.058* |
C26 | −0.2978(3) | −0.47437(16) | −0.4119(3) | 0.0417(8) |
C27 | −0.2109(3) | −0.52829(15) | −0.4511(3) | 0.0397(7) |
C28 | −0.1951(4) | −0.5342(2) | −0.5657(3) | 0.0621(11) |
H28A | −0.2404 | −0.5059 | −0.6161 | 0.074* |
C29 | −0.1123(5) | −0.5820(2) | −0.6048(4) | 0.0841(15) |
H29A | −0.1038 | −0.5869 | −0.6820 | 0.101* |
C30 | −0.0423(5) | −0.6222(2) | −0.5311(4) | 0.0796(14) |
H30A | 0.0144 | −0.6541 | −0.5583 | 0.096* |
C31 | −0.0553(4) | −0.6158(2) | −0.4162(4) | 0.0646(11) |
H31A | −0.0069 | −0.6430 | −0.3660 | 0.078* |
C32 | −0.1408(3) | −0.56885(16) | −0.3761(3) | 0.0458(8) |
H32A | −0.1509 | −0.5647 | −0.2989 | 0.055* |
Source of material
The synthesis of 1,1′-(3,4-diphenylthieno[2,3-b]thiophene-2,5-diyl)bis[1-phenyl-methanone] was carried out using 1,3-diphenyl-1,3-propanedione (1.0 g, 4.46 mmol) and anhydrous potassium carbonate (2.46 g, 17.83 mmol) dissolved in 7 mL N,N-dimethylformamide (DMF), and was stirred vigorously at room temperature for 5 min. Carbon disulfide (0.3 mL, 4.9 mmol) was added with continued stirring for 30 min. The reaction mixture was cooled in an ice bath for 10 min, where 2-chloro-1-phenylethanone (1.1 mL, 9.36 mmol) was introduced dropwise. The reaction mixture was stirred vigorously at room temperature for another 3 h. The precipitates were collected after adding 10 mL of distilled water. The crude reaction mixture was purified by flash chromatography eluting with 20% ethyl acetate/hexanes to provide 1.56 g of the product (70% yield) [1], [2], [3]. The title compound was crystallized from ethanol; whereupon yellow crystals were obtained.
The title compound was characterized by 1H-NMR, 13C-NMR, and single-crystal X-ray diffraction. 1H-NMR (800 MHz, DMSO-6, δ): 7.44 (d, 4H), 7.32 (t, 2H), 7.13 (t, 4H), 6.80 (t, 4H), 6.68 (d, 4H), 6.63 (t, 2H); 13C-NMR (DMSO-6, δ): 190.02, 145.44, 144.02, 141.60, 140.85, 137.20, 132.56, 132.21, 129.73, 129.02, 127.81, 126.87, 126.66.
Experimental details
Hydrogen atoms were placed in calculated positions and were included in the refinement in the riding model approximation, with Uiso(H) set to 1.2Ueq(C).
Discussion
Some thienothiophenes compounds are known for their importance in pharmaceutical applications because of their biological activities, such as anticancer, antioxidant, antimicrobial, antitumor and others [4], [5], [6], [7], [8], [9]. The bioactivity and pharmacological activities for the prepared compound are part of an ongoing study in our laboratories.
The asymmetric unit of the title structure contains only one independent molecule. The dihedral angle between the two thiophene rings is 3.97(4)°. The planes of the phenyl groups (C14—C19) and (C20—C25) make dihedral angle with the mean plane of thieno[2,3-b]thiophene equal to 59.31° and 59.60°, respectively. The molecules were packed in the crystal structure without any hydrogen bonds.
Acknowledgement
This work was sponsored by National Center for Petrochemical Technology (NCPT) at KingAbdulaziz City for Science and Technology (KACST) in Saudi Arabia (Grant No. 33–781).
References
1 Mabkhot, Y. N.; Barakat, A.; Yousuf, S.; Choudhary, M. I.; Frey, W.; Ben Hadda, T.; Mubarak, M. S.: Substituted thieno[2,3-b]thiophenes and related congeners: Synthesis, beta-glucuronidase inhibition activity, crystal structure, and POM analyses. Bioorg. Med. Chem. 22 (2014) 6715–6725.10.1016/j.bmc.2014.08.014Search in Google Scholar PubMed
2 Mabkhot, Y. N.; Aldawsari, F. D.; Al-Showiman, S. S.; Barakat, A.; Soliman, S. M.; Choudhary, M. I.; Yousuf, S.; Mubarak, M. S.; Hadda, T. B.: Novel enaminone derived from thieno [2,3-b] thiene: Synthesis, x-ray crystal structure, HOMO, LUMO, NBO analyses and biological activity. Chem. Cent. J. 9 (2015) 1–11.10.1186/s13065-015-0100-9Search in Google Scholar PubMed PubMed Central
3 Mabkhot, Y. N.; Aldawsari, F. D.; Al-Showiman, S. S.; Barakat, A.; Choudhary, M. I.; Yousuf, S.: Synthesis, characterization, X-ray crystal structure, and antimicrobial activity of 1,1′-(3,4-diphenylthieno[2,3-b]thiophene-2,5-diyl)diethanone. J. Chem. 2014 (2014) 1–5.10.1155/2014/504860Search in Google Scholar
4 Heeney, M.; Bailey, C.; Genevicius, K.; Shkunov, M.; Sparrowe, D.; Tierney, S.; McCulloch, I.: Stable polythiophene semiconductors incorporating thieno[2,3-b]thiophene. J. Am. Chem. Soc. 127 (2005) 1078–1079.10.1021/ja043112pSearch in Google Scholar PubMed
5 Mashraqui, S. H.; Sangvikar, Y. S.; Meetsma, A.: Synthesis and structures of thieno[2,3-b]thiophene incorporated [3.3]dithiacyclophanes. Enhanced first hyperpolarizability in an unsymmetrically polarized cyclophane. Tetrahedron Lett. 47 (2006) 5599–5602.10.1016/j.tetlet.2006.05.098Search in Google Scholar
6 Shefer, N.; Rozen, S.: The oxygenation of thieno[2,3-b]thiophenes. J. Org. Chem. 75 (2010) 4623–4625.10.1021/jo100702fSearch in Google Scholar PubMed
7 Cinar, M. E.; Ozturk, T.: Thienothiophenes, dithienothiophenes, and thienoacenes: syntheses, oligomers, polymers, and properties. Chem. Rev. 115 (2015) 3036–3140.10.1021/cr500271aSearch in Google Scholar PubMed
8 Zubarev, A. A.; Larionova, N. A.; Rodinovskaya, L. A.; Mortikov, V. Y.; Shestopalov, A. M.: Synthesis of 2,5-asymmetrically substituted 3,4-diaminothieno[2,3-b]thiophenes by Domino reaction. ACS Comb. Sci. 15 (2013) 546–550.10.1021/co400069vSearch in Google Scholar PubMed
9 Mabkhot, Y. N.; Aldawsari, F. D.; Al-Showiman, S. S.; Barakat, A.; Hadda, T. B.; Mubarak, M. S.; Naz, S.; Ul-Haq, Z.; Rauf, A.: Synthesis, bioactivity, molecular docking and POM analyses of novel substituted thieno[2,3-b]thiophenes and related congeners. Molecules 20 (2015) 1824–1841.10.3390/molecules20021824Search in Google Scholar PubMed PubMed Central
10 Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Search in Google Scholar PubMed
11 Bruker. APEX2, SAINT and SADABS. Brucker AXS Inc., Madison, WI, USA (2009).Search in Google Scholar
©2017 Rashid Altamimi et al., published by De Gruyter.
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.